We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.89%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$16.7B
AUM Growth
+$10.2M
(+0.06%)
Cap. Flow
-$510M
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
20.67%
Holding
1,686
New
28
Increased
245
Reduced
1,348
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$22.8M |
| 2 |
Cardinal Health
CAH
|
+$16.4M |
| 3 |
Hormel Foods
HRL
|
+$16.3M |
| 4 |
Pentair
PNR
|
+$15.9M |
| 5 |
AbbVie
ABBV
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$70.1M |
| 2 |
Microsoft
MSFT
|
+$56.8M |
| 3 |
Amazon
AMZN
|
+$50.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$24.3M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.86% |
| 2 | Financials | 13.33% |
| 3 | Healthcare | 11.75% |
| 4 | Industrials | 10.99% |
| 5 | Consumer Staples | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
1451
DELISTED
Cymabay Therapeutics
CBAY
| $189K | ﹤0.01% |
26,360
-322
| -1% | -$3.65K |
|
1452
Dianthus Therapeutics
DNTH
$5.74B
| $188K | ﹤0.01% |
798
-4
| -0.5% | -$989 |
|
|
SLCA
1453
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $186K | ﹤0.01% |
14,517
-480
| -3% | -$6.55K |
|
1454
Golar LNG
GLNG
$5.01B
| $185K | ﹤0.01% |
10,020
-264
| -3% | -$5.02K |
|
|
DERM
1455
DELISTED
Dermira, Inc.
DERM
| $185K | ﹤0.01% |
19,363
+1,198
| +7% | +$12.9K |
|
1456
Archrock
AROC
$6.49B
| $183K | ﹤0.01% |
17,221
-362
| -2% | -$3.56K |
|
1457
Puma Biotechnology
PBYI
$413M
| $183K | ﹤0.01% |
14,360
-1,760
| -11% | -$40.5K |
|
1458
Lattice Semiconductor
LSCC
$18.4B
| $181K | ﹤0.01% |
12,408
-324
| -3% | -$4.32K |
|
|
CCXI
1459
DELISTED
ChemoCentryx, Inc.
CCXI
| $180K | ﹤0.01% |
19,319
-287
| -1% | -$3.32K |
|
|
FLXN
1460
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $180K | ﹤0.01% |
14,637
-1,920
| -12% | -$22.2K |
|
1461
First Commonwealth Financial
FCF
$2.14B
| $178K | ﹤0.01% |
13,212
-285
| -2% | -$3.76K |
|
1462
Aurinia Pharmaceuticals
AUPH
$1.98B
| $177K | ﹤0.01% |
26,829
-2,156
| -7% | -$13.7K |
|
1463
BGC Group
BGC
$5.56B
| $177K | ﹤0.01% |
33,899
-227
| -0.7% | -$1.18K |
|
1464
Brookdale Senior Living
BKD
$3.57B
| $177K | ﹤0.01% |
24,579
-3,594
| -13% | -$23.7K |
|
1465
SM Energy
SM
$7.95B
| $176K | ﹤0.01% |
14,036
-772
| -5% | -$11.2K |
|
|
FOE
1466
DELISTED
Ferro Corporation
FOE
| $176K | ﹤0.01% |
11,165
-284
| -2% | -$4.56K |
|
1467
Rigel Pharmaceuticals
RIGL
$679M
| $174K | ﹤0.01% |
6,658
-846
| -11% | -$19.1K |
|
1468
Rambus
RMBS
$10.6B
| $174K | ﹤0.01% |
14,448
-281
| -2% | -$3.22K |
|
1469
Corbus Pharmaceuticals
CRBP
$172M
| $171K | ﹤0.01% |
821
-87
| -10% | -$18.6K |
|
1470
Collegium Pharmaceutical
COLL
$1.15B
| $169K | ﹤0.01% |
12,856
-1,650
| -11% | -$22.1K |
|
1471
Kite Realty
KRG
$5.96B
| $169K | ﹤0.01% |
11,175
-237
| -2% | -$3.74K |
|
|
WDR
1472
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $169K | ﹤0.01% |
10,165
-272
| -3% | -$4.74K |
|
1473
Prothena Corp
PRTA
$461M
| $168K | ﹤0.01% |
15,886
-2,023
| -11% | -$20.8K |
|
1474
BioCryst Pharmaceuticals
BCRX
$2.39B
| $166K | ﹤0.01% |
43,755
-5,356
| -11% | -$32.2K |
|
1475
SIGA Technologies
SIGA
$224M
| $166K | ﹤0.01% |
29,214
-3,812
| -12% | -$21.1K |
|
Similar funds
ProShare Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, ProShare Advisors held 1,686 positions worth $16.7B, up 0.06% from $16.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors withdrew a net $510M in Q2 2019, closing 61 positions and reducing 1,348 holdings. Its most notable exit was Bemis, an estimated $12.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, ProShare Advisors opened a new position in Dow Inc worth $13.3M.
- ProShare Advisors's largest Q2 2019 buy was Dow Inc: 269,509 shares worth $13.3M.
- ProShare Advisors added most to Walgreens Boots Alliance in Q2 2019, an estimated $22.8M increase.
- ProShare Advisors's biggest Q2 2019 reduction was Apple, cutting an estimated $70.1M.
- ProShare Advisors fully exited Bemis in Q2 2019, selling an estimated $12.7M.
- ProShare Advisors's ten largest holdings make up 21% of its $16.7B portfolio in Q2 2019.
- ProShare Advisors opened 28 new positions and closed 61 in Q2 2019.
- ProShare Advisors's portfolio value rose 0.06% quarter-over-quarter to $16.7B.
Based on ProShare Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.